NAMPT and neoplasm: However, recent data show that tumor cells, which must maintain high concentrations of NAD to prevent oxidative stress caused by their increased metabolic activity and rapid proliferation [30], are very sensitive to killing by FK866, a drug that specifically inhibits NAMPT, the rate limiting enzyme in the NAM-dependent NAD salvage biosynthetic pathway [31, 32].